ERAS Erasca, Inc. - Common Stock
ERAS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ERAS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
ERAS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 5 29.4%
- Buy 9 52.9%
- Hold 3 17.6%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
10 analysts · 2026-08-16Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.60 | $-0.21 | -0.39% |
| Dec. 31, 2025 | $-0.10 | $-0.11 | 0.01% |
| Sept. 30, 2025 | $-0.11 | $-0.11 | -0.00% |
| June 30, 2025 | $-0.12 | $-0.11 | -0.01% |
| March 31, 2025 | $-0.11 | $-0.13 | 0.02% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| SG&A Expense | $39M | $42M | $38M | $33M | $23M | $8M | |
| Operating Expenses | $141M | $180M | $142M | $247M | $125M | $109M | |
| Operating Income | $-141M | $-180M | $-142M | $-247M | $-125M | $-109M | |
| Other Non-op | $16M | $18M | $16M | $5M | $314.0K | $-102.0K | |
| Pretax Income | $-125M | $-162M | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-125M | $-162M | $-125M | $-243M | $-123M | $-102M | |
| EPS (Basic) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| EPS (Diluted) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| Shares (Basic) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| Shares (Diluted) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| EBITDA | $-138M | $-176M | $-138M | $-245M | $-124M | · |
Balance Sheet 20
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $68M | $93M | $284M | $360M | $65M | |
| Short-term Investments | $202M | $231M | $219M | $151M | $54M | $53M | |
| Prepaid Expense | $10M | $10M | $8M | $9M | $6M | $1M | |
| Current Assets | $286M | $309M | $321M | $444M | $420M | $120M | |
| PP&E (Net) | $13M | $16M | $22M | $25M | $16M | $2M | |
| PP&E (Gross) | $26M | $26M | $30M | $28M | $18M | $3M | |
| Accum. Depreciation | $13M | $10M | $7M | $4M | $2M | $902.0K | |
| Other Non-current Assets | $1M | $3M | $4M | $5M | $3M | $451.0K | |
| Total Assets | $396M | $503M | $395M | $515M | $501M | $125M | |
| Accounts Payable | $981.0K | $468.0K | $2M | $23M | $5M | $878.0K | |
| Current Liabilities | $29M | $31M | $26M | $49M | $26M | $14M | |
| Capital Leases | $42M | $47M | $52M | $54M | $19M | $2M | |
| Other Non-current Liabilities | $399.0K | $362.0K | $566.0K | $573.0K | $158.0K | · | |
| Total Liabilities | $71M | $79M | $79M | $103M | $45M | $17M | |
| Common Stock | $28.0K | $28.0K | $15.0K | $15.0K | $12.0K | $3.0K | |
| Retained Earnings | $-892M | $-768M | $-606M | $-481M | $-238M | $-115M | |
| AOCI | $628.0K | $405.0K | $77.0K | $-1M | $-162.0K | $2.0K | |
| Stockholders' Equity | $325M | $423M | $317M | $412M | $457M | $-114M | |
| Liabilities + Equity | $396M | $503M | $395M | $515M | $501M | $125M | |
| Shares Outstanding | 284,159,076 | 283,218,344 | 151,090,227 | 149,333,258 | 119,102,505 | 21,923,173 |
Cash Flow 11
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $3M | $829.0K | $540.0K | |
| Stock-based Comp | $25M | $27M | $26M | $20M | $8M | $797.0K | |
| Other Non-cash | $1M | $21M | $-6M | $117M | $34M | · | |
| Operating Cash Flow | $-95M | $-109M | $-101M | $-103M | $-80M | $-33M | |
| CapEx | $128.0K | $60.0K | $2M | $15M | $11M | $947.0K | |
| Investing Cash Flow | $100M | $-157M | $-91M | $-71M | $-65M | $-71M | |
| Stock Issued | · | · | · | $95M | · | · | |
| Net Stock Activity | · | · | · | $95M | · | · | |
| Financing Cash Flow | $1M | $241M | $1M | $98M | $439M | $140M | |
| Net Change in Cash | $6M | $-25M | $-191M | $-76M | $295M | $36M | |
| Free Cash Flow | $-96M | $-109M | $-103M | $-118M | $-91M | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -27.7% | -36.0% | -27.5% | -47.8% | -39.2% | · | |
| ROE | -35.7% | -37.0% | -38.1% | -62.5% | -26.1% | · | |
| ROIC | -43.3% | · | · | · | · | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 | · | |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 | · |
Valuation (TTM) 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-125M | $-162M | $-125M | $-243M | $-123M | · | |
| Market Cap | $1.06B | $711M | $322M | $644M | $1.86B | · | |
| P/E | -8.5 | -3.6 | -2.6 | -2.2 | -8.4 | · | |
| P/B | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Tangible Book | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Cash Flow | -11.1 | -6.5 | -3.2 | -6.2 | -23.3 | · | |
| P / FCF | -11.1 | -6.5 | -3.1 | -5.5 | -20.4 | · | |
| Earnings Yield | -11.8% | -27.5% | -39.0% | -46.2% | -11.9% | · |
Income Statement 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $12M | $11M | $9M | $10M | $9M | $10M | $10M | $10M | $12M | $10M | $9M | $9M | $10M | $9M | $9M | $9M | |
| Operating Expenses | $48M | $188M | $33M | $35M | $38M | $36M | $36M | $37M | $68M | $39M | $34M | $35M | $36M | $37M | $138M | $37M | |
| Operating Income | $-48M | $-188M | $-33M | $-35M | $-38M | $-36M | $-36M | $-37M | $-68M | $-39M | $-34M | $-35M | $-36M | $-37M | $-138M | $-37M | |
| Other Non-op | $4M | $22.0K | $7M | $-37.0K | $4M | $-76.0K | $9M | $173.0K | $5M | $4M | $9M | $-49.0K | $4M | $4M | $3M | $1M | |
| Net Income | $-44M | $-183M | $-29M | $-31M | $-34M | $-31M | $-32M | $-31M | $-63M | $-35M | $-30M | $-30M | $-32M | $-33M | $-135M | $-35M | |
| EPS (Basic) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| EPS (Diluted) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| Shares (Basic) | 311,336,806 | 304,317,460 | -566,763,893 | 283,681,570 | 283,355,730 | 283,260,289 | -417,535,356 | 282,384,964 | 217,806,567 | 151,161,741 | -299,806,452 | 150,450,201 | 150,037,029 | 149,504,216 | -238,458,880 | 120,798,322 | |
| Shares (Diluted) | 311,336,806 | 304,317,460 | -566,763,893 | 283,681,570 | 283,355,730 | 283,260,289 | -417,535,356 | 282,384,964 | 217,806,567 | 151,161,741 | -299,806,452 | 150,450,201 | 150,037,029 | 149,504,216 | -238,458,880 | 120,798,322 | |
| EBITDA | $-47M | $-187M | · | $-34M | $-37M | $-35M | · | $-36M | $-67M | $-38M | · | $-34M | $-35M | $-36M | · | $-36M |
Balance Sheet 20
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $47M | $74M | $70M | $66M | $70M | $68M | $69M | $173M | $77M | $93M | $113M | $139M | $273M | $284M | $219M | |
| Short-term Investments | $226M | $197M | $202M | $218M | $235M | $234M | $231M | $250M | $236M | $221M | $219M | $184M | $178M | $117M | $151M | $137M | |
| Prepaid Expense | $10M | $10M | $10M | $12M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $9M | $7M | $8M | $9M | $10M | |
| Current Assets | $278M | $254M | $286M | $300M | $311M | $315M | $309M | $330M | $418M | $307M | $321M | $306M | $324M | $398M | $444M | $366M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $16M | $17M | $18M | $21M | $22M | $23M | $24M | $25M | $25M | $25M | |
| PP&E (Gross) | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $30M | $30M | $30M | $29M | $29M | $28M | $27M | |
| Accum. Depreciation | $14M | $13M | $13M | $12M | $11M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Accounts Payable | $2M | $2M | $981.0K | $3M | $2M | $2M | $468.0K | $2M | $2M | $3M | $2M | $4M | $3M | $3M | $23M | $4M | |
| Current Liabilities | $34M | $27M | $29M | $29M | $28M | $25M | $31M | $30M | $25M | $30M | $26M | $27M | $23M | $26M | $49M | $28M | |
| Capital Leases | $39M | $41M | $42M | $43M | $45M | $46M | $47M | $48M | $50M | $51M | $52M | $53M | $54M | $55M | $54M | $53M | |
| Other Non-current Liabilities | $341.0K | $340.0K | $399.0K | $395.0K | $263.0K | $251.0K | $362.0K | $340.0K | $82.0K | $559.0K | $566.0K | $761.0K | $697.0K | $630.0K | $573.0K | · | |
| Total Liabilities | $73M | $68M | $71M | $73M | $73M | $72M | $79M | $79M | $75M | $82M | $79M | $80M | $78M | $81M | $103M | $81M | |
| Common Stock | $31.0K | $31.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $27.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $12.0K | |
| Retained Earnings | $-1.12B | $-1.08B | $-892M | $-863M | $-833M | $-799M | $-768M | $-735M | $-704M | $-641M | $-606M | $-576M | $-546M | $-514M | $-481M | $-346M | |
| AOCI | $-1M | $-699.0K | $628.0K | $649.0K | $415.0K | $628.0K | $405.0K | $2M | $-196.0K | $-210.0K | $77.0K | $-575.0K | $-793.0K | $-514.0K | $-1M | $-1M | |
| Stockholders' Equity | $362M | $394M | $325M | $348M | $372M | $400M | $423M | $450M | $451M | $288M | $317M | $339M | $363M | $386M | $412M | $365M | |
| Liabilities + Equity | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Shares Outstanding | 312,556,206 | 310,806,888 | 284,159,076 | 283,711,805 | 283,650,139 | 283,265,716 | 283,218,344 | 282,690,975 | 273,039,997 | 151,249,219 | 151,090,227 | 150,537,752 | 150,383,261 | 149,699,528 | 149,333,258 | 121,024,938 |
Cash Flow 11
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $716.0K | $723.0K | $743.0K | $755.0K | $787.0K | $822.0K | $865.0K | $842.0K | $1M | $998.0K | $942.0K | $941.0K | $955.0K | $894.0K | $933.0K | $771.0K | |
| Stock-based Comp | $10M | $8M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | |
| Other Non-cash | · | $147M | · | · | · | $-8M | · | · | · | $-6M | · | · | · | $-898.0K | · | · | |
| Operating Cash Flow | $-27M | $-27M | $-22M | $-22M | $-21M | $-32M | $-25M | $-22M | $-29M | $-33M | $-25M | $-24M | $-26M | $-26M | $-26M | $-24M | |
| CapEx | $8.0K | $36.0K | $9.0K | $6.0K | $30.0K | $83.0K | $0 | $5.0K | $13.0K | $42.0K | $82.0K | $240.0K | $247.0K | $1M | $864.0K | $2M | |
| Investing Cash Flow | $19M | $-244M | $25M | $26M | $16M | $34M | $23M | $-103M | $-87M | $10M | $5M | $-2M | $-109M | $15M | $-5M | $-55M | |
| Stock Issued | $0 | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $245M | $575.0K | $41.0K | $447.0K | $33.0K | $801.0K | $21M | $212M | $7M | $456.0K | $7.0K | $649.0K | $183.0K | $96M | $427.0K | |
| Net Change in Cash | $-5M | $-27M | $4M | $4M | $-4M | $3M | $-1M | $-104M | $96M | $-16M | $-20M | $-26M | $-134M | $-11M | $65M | $-79M | |
| Free Cash Flow | · | $-27M | · | · | · | $-32M | · | · | · | $-33M | · | · | · | $-28M | · | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.0% | -39.3% | · | -6.5% | -7.0% | -7.4% | · | -6.6% | -13.1% | -8.4% | · | -7.0% | -7.2% | -7.0% | · | -7.3% | |
| ROE | -12.0% | -46.3% | · | -7.7% | -8.2% | -9.0% | · | -7.9% | -15.5% | -10.4% | · | -8.6% | -8.4% | -8.2% | · | -8.4% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 9.5 | · | 10.4 | 11.0 | 12.4 | · | 11.0 | 16.8 | 10.1 | · | 11.4 | 13.9 | 15.6 | · | 13.2 | |
| Quick Ratio | 8.0 | 9.1 | · | 10.0 | 10.7 | 12.0 | · | 10.6 | 16.4 | 9.8 | · | 11.1 | 13.6 | 15.3 | · | 12.9 |
Valuation (TTM) 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-292M | $-279M | · | $-127M | $-159M | $-160M | · | $-160M | $-160M | $-130M | · | $-131M | $-136M | $-141M | · | $-154M | |
| Market Cap | $5.73B | $5.03B | · | $618M | $360M | $388M | · | $772M | $644M | $312M | · | $297M | $415M | $451M | · | $944M | |
| P/E | -18.9 | -17.2 | · | -4.8 | -2.0 | -1.9 | · | -3.3 | -2.5 | -2.4 | · | -2.1 | -2.7 | -2.7 | · | -5.7 | |
| P/B | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Tangible Book | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | -183.6 | · | · | · | -12.3 | · | · | · | -9.4 | · | · | · | -17.1 | · | · | |
| P / FCF | · | -183.4 | · | · | · | -12.3 | · | · | · | -9.4 | · | · | · | -16.3 | · | · | |
| Earnings Yield | -5.3% | -5.8% | · | -20.6% | -49.6% | -54.0% | · | -30.4% | -39.4% | -41.8% | · | -46.7% | -37.0% | -37.2% | · | -17.4% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Income | $-125M | $-162M | $-125M | $-243M | $-123M |
| Diluted EPS | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-96M | $-109M | $-103M | $-118M | $-91M |
Latest News Recent headlines mentioning this company
- Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20
- Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%
- Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
- JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels
- Erasca (ERAS) Climbs 390% YTD on ‘Best-in-Class’ Potential of Cancer Treatment
- What’s Driving Erasca (ERAS)’s Nearly 355% YTD Return
- Erasca (ERAS) Adds 13%; Soars 310% YTD
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 277 filers · $4.2B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 74 (-16 vs prior Q) | 25 (+4 vs prior Q) | 100 (+23 vs prior Q) | 71 (+32 vs prior Q) | +30.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $457,545,444 | 24,975,188 | 11.02% | Shares |
| RTW INVESTMENTS, LP | $328,784,533 | 17,946,754 | 7.92% | Shares |
| Venrock Adviser, LLC | $327,777,996 | 17,891,812 | 7.89% | Shares |
| STATE STREET CORP | $223,221,048 | 12,184,555 | 5.37% | Shares |
| Logos Global Management LP | $222,588,000 | 12,150,000 | 5.36% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $208,888,286 | 11,402,199 | 5.03% | Shares |
| Siren, L.L.C. | $208,807,348 | 11,397,781 | 5.03% | Shares |
| Paradigm Biocapital Advisors LP | $174,956,000 | 9,550,000 | 4.21% | Shares |
| ARCH Venture Management, LLC | $129,917,324 | 7,091,557 | 3.13% | Shares |
| Cormorant Asset Management, LP | $109,920,000 | 6,000,000 | 2.65% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $103,973,538 | 5,674,177 | 2.50% | Shares |
| Affinity Asset Advisors, LLC | $96,180,000 | 5,250,000 | 2.32% | Shares |
| Vivo Capital, LLC | $75,614,188 | 4,127,412 | 1.82% | Shares |
| Caption Management, LLC | $68,535,120 | 3,741,000 | 1.65% | Call option |
| ALLIANCEBERNSTEIN L.P. | $66,639,175 | 4,118,614 | 1.60% | Shares |
| GOLDMAN SACHS GROUP INC | $61,635,625 | 3,364,390 | 1.48% | Shares |
| FMR LLC | $52,713,528 | 2,877,376 | 1.27% | Shares |
| a16z Capital Management, L.L.C. | $52,441,000 | 2,862,500 | 1.26% | Shares |
| Woodline Partners LP | $51,879,803 | 2,831,867 | 1.25% | Shares |
| JENNISON ASSOCIATES LLC | $51,083,708 | 2,788,412 | 1.23% | Shares |
| Soleus Capital Management, L.P. | $49,464,000 | 2,700,000 | 1.19% | Shares |
| BANK OF AMERICA CORP /DE/ | $47,608,477 | 2,598,716 | 1.15% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $43,782,308 | 2,389,864 | 1.05% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $37,410,063 | 2,042,034 | 0.90% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35,628,553 | 1,944,790 | 0.86% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $35,475,984 | 1,936,462 | 0.85% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $31,107,195 | 1,697,991 | 0.75% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $29,616,277 | 1,616,609 | 0.71% | Shares |
| UBS Group AG | $29,005,287 | 1,583,258 | 0.70% | Shares |
| STEMPOINT CAPITAL LP | $28,687,526 | 1,565,913 | 0.69% | Shares |
| Rock Springs Capital Management LP | $25,687,388 | 1,402,150 | 0.62% | Shares |
| Evergreen Quality Fund GP, Ltd. | $25,195,496 | 1,375,300 | 0.61% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $25,078,578 | 1,368,918 | 0.60% | Shares |
| FRED ALGER MANAGEMENT, LLC | $23,970,896 | 1,308,455 | 0.58% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23,138,636 | 1,263,026 | 0.56% | Shares |
| Point72 Asset Management, L.P. | $22,848,759 | 1,247,203 | 0.55% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22,780,920 | 1,243,500 | 0.55% | Call option |
| First Turn Management, LLC | $22,381,929 | 1,221,721 | 0.54% | Shares |
| Caption Management, LLC | $19,075,242 | 1,041,225 | 0.46% | Shares |
| Integral Health Asset Management, LLC | $18,320,000 | 1,000,000 | 0.44% | Shares |
| D. E. Shaw & Co., Inc. | $17,152,833 | 936,290 | 0.41% | Shares |
| MILLENNIUM MANAGEMENT LLC | $16,667,792 | 909,814 | 0.40% | Shares |
| SAMLYN CAPITAL, LLC | $15,782,405 | 861,485 | 0.38% | Shares |
| Assenagon Asset Management S.A. | $14,891,888 | 812,876 | 0.36% | Shares |
| MARSHALL WACE, LLP | $13,534,999 | 738,810 | 0.33% | Shares |
| Caption Management, LLC | $13,245,360 | 723,000 | 0.32% | Put option |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $13,142,353 | 718,554 | 0.32% | Shares |
| Capital World Investors | $12,908,309 | 704,602 | 0.31% | Shares |
| CITIGROUP INC | $12,860,310 | 701,982 | 0.31% | Shares |
| JANE STREET GROUP, LLC | $12,752,552 | 696,100 | 0.31% | Call option |
| TD Asset Management Inc | $12,112,305 | 661,152 | 0.29% | Shares |
| Balyasny Asset Management L.P. | $12,057,766 | 658,175 | 0.29% | Shares |
| Balyasny Asset Management L.P. | $10,992,000 | 600,000 | 0.26% | Call option |
| AMERIPRISE FINANCIAL INC | $10,038,170 | 547,935 | 0.24% | Shares |
| JANE STREET GROUP, LLC | $9,855,116 | 537,943 | 0.24% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,649,144 | 526,700 | 0.23% | Put option |
| ORBIMED ADVISORS LLC | $9,084,888 | 495,900 | 0.22% | Shares |
| Polymer Capital Management (HK) LTD | $8,757,326 | 478,020 | 0.21% | Shares |
| BlackRock, Inc. | $8,538,732 | 466,088 | 0.21% | Shares |
| KVP Capital Advisors, LP | $8,335,600 | 455,000 | 0.20% | Shares |
| Spruce Street Capital LP | $7,740,988 | 422,543 | 0.19% | Shares |
| Pictet Asset Management Holding SA | $7,194,043 | 393,288 | 0.17% | Shares |
| Cinctive Capital Management LP | $7,174,881 | 391,642 | 0.17% | Shares |
| CITADEL ADVISORS LLC | $6,961,600 | 380,000 | 0.17% | Call option |
| Rhenman & Partners Asset Management AB | $6,393,680 | 349,000 | 0.15% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6,369,058 | 347,656 | 0.15% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $6,225,136 | 339,800 | 0.15% | Shares |
| EcoR1 Capital, LLC | $6,045,600 | 330,000 | 0.15% | Shares |
| Swiss National Bank | $5,714,008 | 311,900 | 0.14% | Shares |
| Longaeva Partners L.P. | $5,245,419 | 286,322 | 0.13% | Shares |
| SIMPLEX TRADING, LLC | $5,074,420 | 276,988 | 0.12% | Shares |
| VANGUARD GROUP INC | $4,976,928 | 1,337,884 | 0.12% | Shares |
| E Fund Management Co., Ltd. | $4,861,780 | 265,381 | 0.12% | Shares |
| ACUTA CAPITAL PARTNERS, LLC | $4,858,446 | 265,199 | 0.12% | Shares |
| Parkman Healthcare Partners LLC | $4,739,091 | 258,684 | 0.11% | Shares |
| RHUMBLINE ADVISERS | $4,696,633 | 256,367 | 0.11% | Shares |
| ROYAL BANK OF CANADA | $4,580,000 | 250,000 | 0.11% | Shares |
| CITADEL ADVISORS LLC | $4,354,664 | 237,700 | 0.10% | Put option |
| ArrowMark Colorado Holdings LLC | $3,864,183 | 210,927 | 0.09% | Shares |
| Seven Fleet Capital Management LP | $3,853,539 | 210,346 | 0.09% | Shares |
| Rafferty Asset Management, LLC | $3,782,402 | 206,463 | 0.09% | Shares |
| Man Group plc | $3,710,771 | 202,553 | 0.09% | Shares |
| WELLS FARGO & COMPANY/MN | $3,345,232 | 182,600 | 0.08% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3,307,985 | 204,449 | 0.08% | Shares |
| Moody Aldrich Partners LLC | $3,259,842 | 177,939 | 0.08% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $3,151,150 | 172,006 | 0.08% | Shares |
| JANE STREET GROUP, LLC | $2,964,176 | 161,800 | 0.07% | Put option |
| HighVista Strategies LLC | $2,937,208 | 160,328 | 0.07% | Shares |
| Atom Investors LP | $2,927,738 | 159,811 | 0.07% | Shares |
| Quantinno Capital Management LP | $2,735,121 | 149,297 | 0.07% | Shares |
| NOMURA HOLDINGS INC | $2,610,600 | 142,500 | 0.06% | Shares |
| Squarepoint Ops LLC | $2,477,469 | 135,233 | 0.06% | Shares |
| PFM Health Sciences, LP | $2,456,492 | 134,088 | 0.06% | Shares |
| Holocene Advisors, LP | $2,318,396 | 126,550 | 0.06% | Shares |
| WELLS FARGO & COMPANY/MN | $2,315,648 | 126,400 | 0.06% | Call option |
| EDBI Pte Ltd | $2,231,109 | 888,888 | 0.05% | Shares |
| Vanguard Global Advisers, LLC | $2,161,815 | 118,003 | 0.05% | Shares |
| Corient Private Wealth LP | $2,150,348 | 117,377 | 0.05% | Shares |
| MetLife Investment Management, LLC | $2,143,293 | 116,992 | 0.05% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $2,135,654 | 116,575 | 0.05% | Shares |
Company insiders 13 insiders · 5 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jonathan E Lim | Chairman & CEO | Jan. 29, 2026 A | 12,899,360 | 0 | 0 | $0 |
| David M. Chacko | CFO and CBO | Jan. 29, 2026 A | 279,980 | 0 | 0 | $0 |
| Ebun Garner | Chief Legal Officer | April 1, 2026 M | 25,076 | 0 | 2 | $-1,982,800 |
| Shannon Morris | Chief Medical Officer | March 4, 2025 M | 0 | 0 | 1 | $-300,800 |
| Lin Wei | Chief Medical Officer | Feb. 1, 2023 A | 315,812 | 0 | 0 | $0 |
| James Arthur Bristol | Director | June 26, 2026 A | 20,000 | 0 | 0 | $0 |
| Valerie Denise Harding Start | Director | June 26, 2026 A | 20,000 | 0 | 0 | $0 |
| Pratik S Multani | Director | June 26, 2026 A | 6,200 | 0 | 0 | $0 |
| Julie Hambleton | Director | June 26, 2026 A | 6,000 | 0 | 0 | $0 |
| Alexander W. Casdin | Director | June 26, 2026 A | 573,974 | 0 | 0 | $0 |
| Jean I Liu | Director | June 26, 2026 A | — | 0 | 0 | $0 |
| Michael David Varney | Director | Jan. 29, 2026 A | — | 0 | 0 | $0 |
| Charles S. Fuchs | — | Aug. 10, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP, Bihua Chen ×4 filings | Jan. 30, 2024 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 47 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 2.87% | 384,783 SH | Aug. 8, 2026 | Daily |
| BBC · ETFis Series Trust I | 2.19% | 76,668 NS | April 30, 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 1.64% | 400,259 SH | Aug. 8, 2026 | Daily |
| CANC · Tema ETF Trust | 1.08% | 147,828 NS | May 31, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.56% | 271,194 NS | April 30, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.39% | 16,922 SH | Aug. 8, 2026 | Daily |
| IBB · iShares Trust | 0.29% | 1,530,081 SH | Aug. 8, 2026 | Daily |
| FSCC · Federated Hermes ETF Trust | 0.29% | 62,243 NS | May 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.25% | 1,997,856 SH | Aug. 8, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.22% | 244,429 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.22% | 214,594 SH | Aug. 8, 2026 | Daily |
| BIB · ProShares Trust | 0.20% | 11,444 NS | May 31, 2026 | N-PORT |
| ESSC · Strategy Shares | 0.18% | 4,365 NS | April 30, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.14% | 21,222 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.13% | 5,592,531 SH | Aug. 8, 2026 | Daily |
| ISCV · iShares Trust | 0.13% | 48,366 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.11% | 1,151,944 SH | Aug. 8, 2026 | Daily |
| SMLF · iShares Trust | 0.10% | 237,029 SH | Aug. 8, 2026 | Daily |
| SMMV · iShares Trust | 0.08% | 13,271 SH | Aug. 8, 2026 | Daily |
| ESML · iShares Trust | 0.08% | 129,228 SH | Aug. 8, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.08% | 123,380 SH | Aug. 8, 2026 | Daily |
| SCHA · SCHWAB STRATEGIC TRUST | 0.06% | 1,147,686 NS | May 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.06% | 82,173 NS | April 30, 2026 | N-PORT |
| ITWO · ProShares Trust | 0.06% | 8,927 NS | May 31, 2026 | N-PORT |
| ISCB · iShares Trust | 0.06% | 9,608 SH | Aug. 8, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.05% | 2,745,733 SH | Aug. 8, 2026 | Daily |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.05% | 394 NS | May 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.04% | 467,663 SH | Aug. 8, 2026 | Daily |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 27,794 NS | May 31, 2026 | N-PORT |
| UWM · ProShares Trust | 0.04% | 6,982 NS | May 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 78,076 NS | April 30, 2026 | N-PORT |
| WSML · iShares Trust | 0.03% | 10,376 SH | Aug. 8, 2026 | Daily |
| URTY · ProShares Trust | 0.03% | 7,067 NS | May 31, 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 43,576 NS | May 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.02% | 263,455 NS | April 30, 2026 | N-PORT |
| HDG · ProShares Trust | 0.01% | 177 NS | May 31, 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 6,020 NS | May 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 8,386,105 SH | Aug. 8, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16,688 SH | Aug. 8, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 402,637 NS | April 30, 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 76,593 NS | May 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.01% | 334,895 SH | Aug. 8, 2026 | Daily |
| IWV · iShares Trust | 0.01% | 58,513 SH | Aug. 8, 2026 | Daily |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 136,333 NS | May 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 18,981 NS | April 30, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 33,981 NS | April 30, 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.00% | 196 NS | May 31, 2026 | N-PORT |